信诺(CI.US)与诺和诺德(NVO.US)、礼来(LLY.US)达成协议以扩大减肥药覆盖范围

智通财经03-07

智通财经APP获悉，据报道，健康保险公司信诺集团(CI.US)已与制药巨头诺和诺德(NVO.US)和礼来(LLY.US)达成协议，以扩大对这两家公司旗下减肥药物的覆盖范围。此举旨在限制雇主出资的医疗保险计划为备受追捧的减肥药物支付的金额。据悉，这份协议是由信诺旗下药品福利管理公司Express Scripts与上述两家制药巨头达成的，该协议是一项旨在解决雇主对减肥药这类药物成本上升的担忧的计划中的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2417763852?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-07 20:54","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2417763852","market":"us","top_or_hot":-1,"title":"信诺(CI.US)与诺和诺德(NVO.US)、礼来(LLY.US)达成协议 以扩大减肥药覆盖范围","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，据报道，健康保险公司信诺集团(CI.US)已与制药巨头诺和诺德(NVO.US)和礼来(LLY.US)达成协议，以扩大对这两家公司旗下减肥药物的覆盖范围。此举旨在限制雇主出资的医疗保险计划为备受追捧的减肥药物支付的金额。据悉，这份协议是由信诺旗下药品福利管理公司Express Scripts与上述两家制药巨头达成的，该协议是一项旨在解决雇主对减肥药这类药物成本上升的担忧的计划中的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072059318b130c8d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>信诺(CI.US)与诺和诺德(NVO.US)、礼来(LLY.US)达成协议 以扩大减肥药覆盖范围</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n信诺(CI.US)与诺和诺德(NVO.US)、礼来(LLY.US)达成协议 以扩大减肥药覆盖范围\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-07 20:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072059318b130c8d&s=b><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，据报道，健康保险公司信诺集团(CI.US)已与制药巨头诺和诺德(NVO.US)和礼来(LLY.US)达成协议，以扩大对这两家公司旗下减肥药物的覆盖范围。此举旨在限制雇主出资的医疗保险计划为备受追捧的减肥药物支付的金额。据悉，这份协议是由信诺旗下药品福利管理公司Express Scripts与上述两家制药巨头达成的，该协议是一项旨在解决雇主对减肥药这类药物成本上升的担忧的计划中的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072059318b130c8d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0058720904.USD","symbol_name":"联博国际健康护理基金A","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072059318b130c8d&s=b","article_id":"2417763852","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072059318b130c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2417763852","pubTimestamp":1709816052,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"智通财经APP获悉，据报道，健康保险公司信诺集团 已与制药巨头诺和诺德和礼来达成协议，以扩大对这两家公司旗下减肥药物的覆盖范围。据悉，这份协议是由信诺旗下药品福利管理公司Express Scripts与上述两家制药巨头达成的，该协议是一项旨在解决雇主对减肥药这类药物成本上升的担忧的计划中的一部分。尽管市场对这类减肥药物的需求正在不断攀升，但在这类药物上的支出可能导致购买药物的保险公司、雇主和政府项目不堪重负。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0058720904.USD":"联博国际健康护理基金A","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","CI":"信诺保险","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0882574055.USD":"富达全球健康医疗A ACC","SG9999014898.SGD":"United Global Quality Growth Fund Dis SGD","LU0122379950.USD":"贝莱德世界健康科学A2","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","LLY":"礼来","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","SG9999014880.SGD":"大华全球优质成长基金Acc SGD","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","NVO":"诺和诺德","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","BK4585":"ETF&股票定投概念","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","BK4534":"瑞士信贷持仓","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU1712237335.SGD":"Natixis Mirova Global Sustainable Equity H-R-NPF/A SGD","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","BK4196":"保健护理服务","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","BK4007":"制药"},"translate_title":"Cigna (CI.US), Novo Nordisk (NVO.US), Lilly (LLY.US) reached an agreement to expand the coverage of diet pills","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":1,"CI":1,"LLY":1},"content_text":"智通财经APP获悉，据报道，健康保险公司信诺集团(CI.US)已与制药巨头诺和诺德(NVO.US)和礼来(LLY.US)达成协议，以扩大对这两家公司旗下减肥药物的覆盖范围。此举旨在限制雇主出资的医疗保险计划为备受追捧的减肥药物支付的金额。据悉，这份协议是由信诺旗下药品福利管理公司Express Scripts与上述两家制药巨头达成的，该协议是一项旨在解决雇主对减肥药这类药物成本上升的担忧的计划中的一部分。信诺表示，该计划将把GLP-1受体激动剂的每月支出增幅限制在15%以内。在美国，诺和诺德旗下Wegovy和礼来旗下Zepbound这两种减肥药物的标价分别为1349美元/月和1060美元/月。尽管市场对这类减肥药物的需求正在不断攀升，但在这类药物上的支出可能导致购买药物的保险公司、雇主和政府项目不堪重负。对于雇主出资医疗保险计划(Employer-Based Health Plans)来说，新的减肥药加剧了已经长期存在的紧张关系——既要提供有竞争力的福利，又要让雇主和个人都能负担得起保费。与政府医疗保健项目不同，私营保险公司有很大的回旋余地来决定它们愿意和不愿意为哪些药物买单。保险公司面临的问题是，仅仅对减肥药买单说“不”可能还不够，因为这些药物不是普通药物，它们已成了一种文化现象，并得到了无处不在的广告活动的支持。保险公司将尽其所能控制成本，但目前还无法确保能成功达到目标。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2417763852"}

信诺(CI.US)与诺和诺德(NVO.US)、礼来(LLY.US)达成协议 以扩大减肥药覆盖范围

精彩评论

信诺(CI.US)与诺和诺德(NVO.US)、礼来(LLY.US)达成协议以扩大减肥药覆盖范围